Koninklijke Philips NV (AMS:PHIA) received a €29.70 ($34.94) target price from analysts at Morgan Stanley in a research note issued on Tuesday. The brokerage currently has a “neutral” rating on the stock.

Other research analysts have also recently issued research reports about the company. Goldman Sachs Group, Inc. (The) set a €39.00 ($45.88) target price on Koninklijke Philips NV and gave the company a “buy” rating in a research note on Monday, August 14th. Citigroup Inc. set a €36.00 ($42.35) price objective on Koninklijke Philips NV and gave the company a “buy” rating in a research report on Thursday, June 29th. J P Morgan Chase & Co set a €35.00 ($41.18) price objective on Koninklijke Philips NV and gave the company a “buy” rating in a research report on Thursday, June 29th. UBS AG set a €36.00 ($42.35) price objective on Koninklijke Philips NV and gave the company a “buy” rating in a research report on Monday, July 24th. Finally, S&P Global set a €34.00 ($40.00) price objective on Koninklijke Philips NV and gave the company a “buy” rating in a research report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. Koninklijke Philips NV currently has a consensus rating of “Hold” and an average price target of €34.34 ($40.39).

Shares of Koninklijke Philips NV (PHIA) opened at 35.135 on Tuesday. The company’s 50-day moving average price is €34.58 and its 200 day moving average price is €32.45. Koninklijke Philips NV has a one year low of €26.28 and a one year high of €36.12. The company has a market cap of €32.92 billion and a P/E ratio of 22.351.

COPYRIGHT VIOLATION NOTICE: “Koninklijke Philips NV (PHIA) Given a €29.70 Price Target by Morgan Stanley Analysts” was reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/10/24/koninklijke-philips-nv-phia-given-a-29-70-price-target-by-morgan-stanley-analysts.html.

About Koninklijke Philips NV

Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.

Analyst Recommendations for Koninklijke Philips NV (AMS:PHIA)

Receive News & Ratings for Koninklijke Philips NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips NV and related companies with MarketBeat.com's FREE daily email newsletter.